These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 15083485)

  • 1. Parametric modelling of cost data in medical studies.
    Nixon RM; Thompson SG
    Stat Med; 2004 Apr; 23(8):1311-31. PubMed ID: 15083485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semi-parametric modelling for costs of health care technologies.
    Conigliani C; Tancredi A
    Stat Med; 2005 Oct; 24(20):3171-84. PubMed ID: 15568210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parametric modelling of cost data: some simulation evidence.
    Briggs A; Nixon R; Dixon S; Thompson S
    Health Econ; 2005 Apr; 14(4):421-8. PubMed ID: 15685641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of statistical models to predict mental health and substance abuse cost.
    Montez-Rath M; Christiansen CL; Ettner SL; Loveland S; Rosen AK
    BMC Med Res Methodol; 2006 Oct; 6():53. PubMed ID: 17067394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
    Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
    J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap compared.
    Nixon RM; Wonderling D; Grieve RD
    Health Econ; 2010 Mar; 19(3):316-33. PubMed ID: 19378353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian estimation of cost-effectiveness from censored data.
    Heitjan DF; Kim CY; Li H
    Stat Med; 2004 Apr; 23(8):1297-309. PubMed ID: 15083484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS.
    Lambert PC; Sutton AJ; Burton PR; Abrams KR; Jones DR
    Stat Med; 2005 Aug; 24(15):2401-28. PubMed ID: 16015676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the bootstrap in analysing cost data from cluster randomised trials: some simulation results.
    Flynn TN; Peters TJ
    BMC Health Serv Res; 2004 Nov; 4(1):33. PubMed ID: 15550169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on confidence intervals for incremental cost-effectiveness ratios.
    Wang H; Zhao H
    Biom J; 2008 Aug; 50(4):505-14. PubMed ID: 18663759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial.
    Chaudhary MA; Stearns SC
    Stat Med; 1996 Jul; 15(13):1447-58. PubMed ID: 8841654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multilevel modelling of clustered grouped survival data using Cox regression model: an application to ART dental restorations.
    Wong MC; Lam KF; Lo EC
    Stat Med; 2006 Feb; 25(3):447-57. PubMed ID: 16143989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of HIV incubation distributions and some comparative studies.
    Tan WY; Lee SR; Tang SC
    Stat Med; 1996 Jan; 15(2):197-220. PubMed ID: 8614755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bayesian model averaging approach for cost-effectiveness analyses.
    Conigliani C; Tancredi A
    Health Econ; 2009 Jul; 18(7):807-21. PubMed ID: 18792078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of multivariable regression models to analyse cost data.
    Dodd S; Bassi A; Bodger K; Williamson P
    J Eval Clin Pract; 2006 Feb; 12(1):76-86. PubMed ID: 16422782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of bootstrap methods for estimating sample size and analysing health-related quality of life outcomes.
    Walters SJ; Campbell MJ
    Stat Med; 2005 Apr; 24(7):1075-102. PubMed ID: 15570625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of a multinational RCT with a binary measure of effectiveness and an interacting covariate.
    Willan AR; Kowgier ME
    Health Econ; 2008 Jul; 17(7):777-91. PubMed ID: 17764096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis in colorectal cancer using a semi-Markov model.
    Castelli C; Combescure C; Foucher Y; Daures JP
    Stat Med; 2007 Dec; 26(30):5557-71. PubMed ID: 18058847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Monte Carlo evaluation of three statistical methods used in path analysis.
    McGue M; Wette R; Rao DC
    Genet Epidemiol; 1987; 4(2):129-55. PubMed ID: 3582958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
    Vickers AJ
    BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.